Change in hearing and tinnitus in conservatively managed vestibular schwannomas
- PMID: 18174921
- PMCID: PMC2039713
- DOI: 10.1055/s-2007-984491
Change in hearing and tinnitus in conservatively managed vestibular schwannomas
Abstract
Objectives: The aim of this study was to evaluate the change of hearing and tinnitus in a group of conservatively managed unilateral vestibular schwannomas (VS).
Design: Retrospective case series review.
Setting: Tertiary referral otoneurological and skull base surgery department.
Participants: Seventy patients affected by unilateral VS with at least two audiograms available were retrospectively evaluated.
Main outcome measures: Changes in pure tone average (PTA), speech discrimination score (SDS), and tinnitus were analyzed.
Results: At diagnosis 16 patients (22.9%) had a PTA of 0 to 30 dB and 38 (54.4%) a PTA of 0 to 50 dB. At the end of the follow-up period, 9 patients (12.9%) had a PTA of 0 to 30 dB and 27 (38.7%) had a PTA of 0 to 50 dB, representing a hearing preservation rate of 56% and 70%, respectively. Of patients with both tonal and speech audiometry, 71.4% with class A hearing (PTA < 30 dB/SDS > 70%) maintained their initial hearing and 60% with class A or B hearing (PTA < 50 dB/SDS > 50%) maintained this useful hearing. Forty-two patients (60%) did not show a significant growth in their tumor over the period of observation. In this group of patients the mean PTA after a mean follow-up time of 40 months decreased from 44 dB HL to 50.8 dB HL, with a yearly rate of 2.47 dB HL. The chance of maintaining a PTA of 0 to 30 dB in this group of patients was 57.1% and a PTA of 0 to 50 dB was 81.4%.
Conclusions: In this group of patients affected by VS and managed conservatively with a mean follow-up of 33.3 months, the risk of losing eligibility for hearing preservation surgery was lower than 30%.
Keywords: Vestibular schwannoma; conservative management; hearing preservation.
Figures
Similar articles
-
Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.Otol Neurotol. 2008 Dec;29(8):1179-86. doi: 10.1097/MAO.0b013e31818b6639. Otol Neurotol. 2008. PMID: 18931646
-
The Course of Hearing Loss in Patients With a Progressive Vestibular Schwannoma.Otolaryngol Head Neck Surg. 2023 Sep;169(3):622-632. doi: 10.1002/ohn.277. Epub 2023 Feb 5. Otolaryngol Head Neck Surg. 2023. PMID: 36939458
-
Ultra Long-Term Audiometric Outcomes in the Treatment of Vestibular Schwannoma With the Middle Cranial Fossa Approach.Otol Neurotol. 2018 Feb;39(2):e151-e157. doi: 10.1097/MAO.0000000000001678. Otol Neurotol. 2018. PMID: 29315191
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.Neurosurgery. 2018 Feb 1;82(2):E35-E39. doi: 10.1093/neuros/nyx511. Neurosurgery. 2018. PMID: 29309683
Cited by
-
Vestibular schwannoma coexisting with dermoid cyst: A case report.Oncol Lett. 2024 Jan 25;27(3):121. doi: 10.3892/ol.2024.14256. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38348385 Free PMC article.
-
Surgery of the lateral skull base: a 50-year endeavour.Acta Otorhinolaryngol Ital. 2019 Jun;39(SUPPL. 1):S1-S146. doi: 10.14639/0392-100X-suppl.1-39-2019. Acta Otorhinolaryngol Ital. 2019. PMID: 31130732 Free PMC article. Review.
-
Systematic Review of Hearing Preservation in Observed Vestibular Schwannoma.J Neurol Surg B Skull Base. 2019 Apr;80(2):165-168. doi: 10.1055/s-0039-1679894. Epub 2019 Mar 1. J Neurol Surg B Skull Base. 2019. PMID: 30931224 Free PMC article.
References
-
- Tschudi D C, Linder T E, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol. 2000;21:722–728. - PubMed
-
- Hoistad D L, Melnik G, Mamikoglu B, Battista R, O'Connor C A, Wiet R J. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22:682–685. - PubMed
-
- Fucci M J, Buchman C A, Brackmann D E, Berkliner K I. Acoustic tumor growth:implications for treatment choices. Am J Otol. 1999;20:495–499. - PubMed
-
- Charabi S, Tos M, Thomsen J, Charabi B, Mantoni M. Vestibular schwannoma growth: the continuing controversy. Laryngoscope. 2000;110:1720–1725. - PubMed
-
- Warrick P, Bance M, Rutka J. The risk of hearing loss in nongrowing, conservatively managed acoustic neuromas. Am J Otol. 1999;20:758–762. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous